Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy.
Ir J Med Sci
; 188(1): 69-74, 2019 Feb.
Article
in En
| MEDLINE
| ID: mdl-29948461
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Thyroid Nuclear Factor 1
/
Lung Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ir J Med Sci
Year:
2019
Type:
Article
Affiliation country:
Ireland